Biosynthesis of riboflavine in Corynebacterium species: the purine precursor.
Corynebacterium species lacks the ability to convert either xanthine or guanine to adenine. This defect and the use of the purine nucleoside antibiotic decoyinine, which blocks the conversion of xanthosine monophosphate --> guanosine monophosphate, permit an experimental design in which the interconversion of purines is largely prevented. Cultures of this organism were grown in the presence of decoyinine and various purine supplements. Data obtained by comparing the radioactivity incorporated from guanine-2-(14)C or xanthine-2-(14)C into bacterial guanine, xanthine, and riboflavine indicate that guanine or a close derivative of guanine is the purine precursor of riboflavine.
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002247:Carbon Isotopes; D003352:Corynebacterium / Q000032:analysis / Q000378:metabolism*; D005947:Glucose / Q000378:metabolism; D005998:Glycine / Q000378:metabolism; D006147:Guanine / Q000378:metabolism*; D009705:Nucleosides / Q000494:pharmacology; D009711:Nucleotides / Q000302:isolation & purification; D012256:Riboflavin / Q000096:biosynthesis* / Q000302:isolation & purification; D014970:Xanthines / Q000032:analysis / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D002247:Carbon Isotopes; D009705:Nucleosides; D009711:Nucleotides; D014970:Xanthines; D006147:Guanine; D005947:Glucose; D005998:Glycine; D012256:Riboflavin